pharmaceutical
-
Pharmaceutical giants set to lose dominance in urological disorders market
Major pharmaceutical companies are predicted to lose their footing in the urological disorders market by 2017, a report by GBI Research has found.
pharmaceutical | 17 May 2012
-
Kuehne + Nagel launches innovative airfreight solution for pharmaceutical products
KN PharmaChain offers – among other features – door-to-door temperature control, a 24 hour alert system, optional wireless temperature measuring and best practice (GxP) standards for facilities, working processes and training programmes.
pharmaceutical | 08 May 2012
-
Aslan Pharmaceuticals selects PharmaNet/i3 as partner for oncology development
Aslan Pharmaceuticals has selected PharmaNet/i3 as a partner supporting the development of their oncology portfolio in Asia.
pharmaceutical | 02 May 2012
-
INCIVEK is well tolerated with commonly used Atripla- and Reyataz-based HIV treatment regimens
Phase 2 study of INCIVEK combination regimen shows 74 percent of people co-infected with hepatitis C, HIV had undetectable hepatitis C virus 12 weeks after treatment ended.
pharmaceutical | 30 April 2012
-
China remains one of the fastest growing pharmaceutical markets in the world
China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.
pharmaceutical | 27 April 2012
-
Pharmaceutical companies from Japan, India and China are amongst Asia Pacific’s most innovative
Pharmaceutical companies from Japan, India and China were among Asia Pacific’s leading innovators last year according to one of two reports released by Thomson Reuters, which provide new insights into global patent and trademark trends throughout 2011.
pharmaceutical | 28 March 2012
-
Agilent launches next-generation pharmaceutical compliance service
The updated software enables delivery of even more reliable, secure and cost-efficient analytical instrument qualification services to the pharmaceutical industry.
pharmaceutical | 20 March 2012
-
Pharmaceutical circulation enterprises see relatively low profit margin in China
In China, pharmaceutical circulation enterprises see relatively low profit margin due to many circulation links. By sales value, some 20 percent of drugs are sold to consumers through pharmaceutical retail firms, and the rest (80 percent) are sold out through hospitals (including hospitals, community and township hospitals), according to Research and Markets.
pharmaceutical | 19 March 2012
-
Vietnam will continue to rely heavily on pharmaceutical imports
Despite strong growth potential, the government's protectionist policy of preventing foreign owned companies from distributing their products and other regulatory inefficiencies will continue to hinder the development of the pharmaceutical sector in the country.
pharmaceutical | 16 March 2012
-
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases (NTDs). Averaging 1.4 billion treatments annually, the donations build upon companies’ existing medicines donation programs which already reach millions of people around the world.
pharmaceutical | 09 February 2012
